Keyword: Takeda Pharmaceutical
Pfizer exits a JV with China's Hisun Pharma, FDA approved the first digital medicine, and Astellas was added to a charity donation probe.
Takeda, along with Lundbeck and Advocate Health Care, will study an app to track and measure patients’ experience on antidepressant therapies.
Takeda Pharma is positioning itself to take over stem cell production in Europe from its partner TiGenix by 2021 after Swissmedic accepted for review the file for an investigational drug to treat patients with Crohn’s disease.
Japanese pharmaceutical giant Takeda said it has completed construction of its new $111 million manufacturing plant in Oranienburg, Germany.
Takeda is starting work on a €40 million plant to manufacture multiple myeloma drug Ninlaro at its site in Ireland, where it will add 40 new jobs.
Nonprofit executive Ethan Brewster can suddenly create body doubles of himself. If it sounds like a Marvel superhero comic plot, that’s because it is.
Takeda has partnered with digital health tools venture Cognition Kit to collect active and passive patient data for a deep dive on depression.
There’s a new spokescharacter lurking around for Prevacid24. The animated ball of fire with a mischievous glint in his eye is the Lurker.
In this week's FiercePharmaAsia wrap-up, Takeda and VC Lightstone have joined forces in forming a neuroscience startup, China's cancer research is narrowing the U.S. lead, Sun's Halol plant was hit by FDA notice again, and more.
Japan’s Takeda is making a big push with a vaccine for dengue and says to be prepared it will build a €100 million plant at its manufacturing site in Singen, Germany.